Estudo de toxicidade aguda de galactomannas bioativas de sementes de duas leguminosas não tradicionais

Autores

  • Fabrícia da Cunha Jácome Marques Superior Institute of Biomedical Sciences, Universidade Estadual do Ceará, Fortaleza, CE, Brazil https://orcid.org/0000-0002-1560-0741
  • Francisco Glerison da Silva Nascimento Superior Institute of Biomedical Sciences, Universidade Estadual do Ceará, Fortaleza, CE, Brazil https://orcid.org/0000-0003-2481-5733
  • Dayanne Terra Tenório Nonato Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil https://orcid.org/0000-0001-9477-1866
  • Ana Maria Sampaio Assreuy Superior Institute of Biomedical Sciences, Universidade Estadual do Ceará, Fortaleza, CE, Brazil https://orcid.org/0000-0002-2323-5385
  • Edna Maria Camelo Chaves Superior Institute of Biomedical Sciences, Universidade Estadual do Ceará, Fortaleza, CE, Brazil https://orcid.org/0000-0001-9658-0377
  • Gislei Frota Aragão Superior Institute of Biomedical Sciences, Universidade Estadual do Ceará, Fortaleza, CE, Brazil https://orcid.org/0000-0002-0689-8371
  • Pedro Marcos Gomes Soares Department of Morphology, Universidade Federal do Ceará, Fortaleza, CE, Brazil https://orcid.org/0000-0003-0606-2539
  • Rondinelle Ribeiro Castro Superior Institute of Biomedical Sciences, Universidade Estadual do Ceará, Fortaleza, CE, Brazil https://orcid.org/0000-0002-9399-4109

DOI:

https://doi.org/10.1590/1983-21252025v3812704rc

Palavras-chave:

Polissacarídeo. Galactomanana. Segurança. Flor-de-pavão. Flamboiã.

Resumo

Fontes não tradicionais de galactomananas são amplamente cultivadas na Região Nordeste do Brasil, como as sementes das espécies ornamentais Caesalpinia pulcherrima (flor-de-pavão) e Delonix regia (flamboiã). As galactomananas GM-CP e GM-DR, extraídas respectivamente dessas sementes, estão sendo estudadas como potenciais agentes terapêuticos, mas avaliações sistemáticas sobre a toxicidade aguda das mesmas ainda não foram relatadas. Grupos de três ratas receberam GM-CP ou GM-DR oral (300 mg kg-1), enquanto um grupo controle recebeu veículo (solução salina). Como não houve letalidade, outros grupos receberam doses de 2000 mg kg-1, o que também não causou letalidade. A coleta de órgãos e amostras de sangue foi feita no dia 14. A hipernocicepção mecânica e o influxo de células inflamatórias foram medidos em outros grupos que receberam doses intra-articulares de GM-CP ou GM-DR (200 µg, n = 5 por grupo). Ambas as galactomananas não evocaram alterações fisiológicas/comportamentais ou inflamação articular. Como a DL50 não foi inferior a 2000 mg kg-1, tais polissacarídeos podem ser alocados na classe 5 do Sistema Globalmente Harmonizado para Classificação e Rotulagem de Produtos Químicos.

Downloads

Não há dados estatísticos.

Referências

ALSULIAM, S. M. et al. Fenugreek seed galactomannan aqueous and extract protects against diabetic noephopathy and liver damage by targeting NF-kB and Keap1/Nrf2 axis. Toxics, 10: 362, 2022.

BRINGEL, P. H. S. F. et al. The lectin isolated from the alga Hypnea cervicornis promotes antinociception in rats subjected to zymosan-induced arthritis: involvement of cGMP signalization and cytokine expression. Inflammation, 43: 1446-1454, 2020.

BURITI, F. C. A. et al. Characterization of partially hydrolysed galactomannan from Caesalpinia pulcherrima seeds as a potential dietary fibre. Food Hydrocolloids, 35: 512-521, 2014.

CHEL-GUERRERO, L. et al. Films properties of QPM corn starch with Delonix regia seed galactomannan as an edible coating material. International Journal of Biological Macromolecules, 255: 128408, 2024.

CUNHA, A. P. et al. Polysaccharides from Caesalpinia ferrea seeds - Chemical characterization and anti-diabetic effects in Wistar rats. Food Hydrocolloids, 65: 68-76, 2017.

CERQUEIRA, M. A. et al. Extraction, purification and characterization of galactomannans from non-traditional sources. Carbohydrate Polymers, 75: 418-414, 2009.

DESHPANDE, P., MOHAN, V., THAKURDESAI, P. Preclinical safety evaluation of low molecular weight galactomannans based standardized fenugreek seeds extract. EXCLI Journal, 15: 446-459, 2016.

JAIN, N. et al. Haemato-biochemical profile following sub acute toxicity of malathion in male albino rats. Pharmacology Online, 2: 500-506, 2009.

JOHNSON, W. et al. Safety Assessment of Galactomannans as Used in Cosmetics. International Journal of Toxicology, 34: 35-65, 2015.

JOSEPH, A. et al. Safety assessment of a fenugreek dietary fiber-based formulation of capsaicinoids-rich red chili (Capsicum annum) extract (Capsifen®): Acute and sub-chronic studies. Toxicology Reports, 7: 602-609, 2020.

LIJU, V. B. et al. Enhanced bioavailability and safety of curcumagalactomannosides as a dietary ingredient. Food and Function, 6: 276-286, 2015.

LIMA, E. L. et al. Injectable hydrogel based on dialdehyde galactomannan and N-succinyl chitosan: a suitable platform for cell culture. Journal of Materials Science: Materials in Medicine, 31: 5-13, 2019.

LIMA, I. C. et al. Galactomannan of Delonix regia seeds modulates cytokine expression and oxidative stress eliciting anti-inflammatory and healing effects in mice cutaneous wound. International Journal of Biological Macromolecules, 203: 342-349, 2022.

MALONE, M. H. Pharmacological approaches to natural product screening and evaluation. In: WAGNER, H.; WOLFF, P. M. (Eds.). New Natural Products and Plant Drugs with Pharmacological, Biological or Therapeutical Activity. Berlin Heldelberg New York: Springer-Verlag, 1977. v. 1, cap. 2, p. 23-53.

MARQUES, F. C. J. et al. Galactomannan from the seeds of Caesalpinia pulcherrima prevents indomethacin-induced gastrointestinal damage via neutrophil migration. International Journal of Biological Macromolecules, 141: 68-75, 2019.

MODI, A. et al. Delonix regia: historic perspectives and modern phytochemical and pharmacological researches. Chinese Journal of Natural Medicines, 14: 31-39, 2016.

NASCIMENTO, F. G. S. et al. Galactomannan of Delonix regia seeds reduces nociception and morphological damage in the rat model of osteoarthritis induced by sodium monoiodoacetate. Naunyn-Schmiedeberg’s Archives of Pharmacology, 394: 491-501, 2021.

OECD.Test No. 423: Acute Oral toxicity - Acute Toxic Class Method, OECD Guidelines for the Testing of Chemicals, Paris: OECD Publishing, 2002, Section 4. Paris.

OGUNJIMI, A. T. et al. Hydrophilic polymeric nanoparticles prepared from Delonix galactomannan with low cytotoxicity for ocular drug delivery. Carbohydrate Polymers, 157: 1065-1075, 2017.

PAWAR, A. H.; LALITHA, K. G. Toxicological Evaluation of Gum (Galactomannans) Isolated from Senna tora Seeds. Journal of Drug Metabolism and Toxicology, 6: 1-5, 2015.

SHARMA, P. et al. A comprehensive review on leguminous galactomannans: structural analysis, functional properties, biosynthesis process and industrial applications

Critical Reviews in Food Science and Nutrition, 62 : 443-465, 2022.

SURYAWANSHI, S. R. et al. Bioavailability enhancement of ondansetron after nasal administration of Caesalpinia pulcherrima-based microspheres. Drug Delivery, 22: 894-902, 2015.

UN - United Nations Globally Harmonized System of Classification and Labelling of Chemicals (GHS). 8 ed. New York and Geneva: UN, 2019.

WANG, R. et al. A contribution to improve barrier properties and reduce swelling ratio of κ-carrageenan film from the incorporation of guar gum or locust bean gum. Polymers, 15: 1751, 2023.

WANG, Z. et al. Estimation of the normal range of blood glucose in rats. Wei Sheng Yan Jiu, 2: 133-140, 2010.

Downloads

Publicado

24-09-2024

Edição

Seção

Artigo Científico